[Extranodal nasal type NK/T-cell lymphoma: clinicopathologic and prognostic study of 55 cases]

Zhonghua Bing Li Xue Za Zhi. 2009 Apr;38(4):237-42.
[Article in Chinese]

Abstract

Objective: To study the clinicopathologic features and prognostic factors of extranodal nasal type NK/T-cell lymphoma (EN-NK/TCL) in Chinese patients.

Methods: Fifty-five cases of EN-NK/TCL diagnosed in Chinese patients during the period from 1998 to 2007 were studied by light microscopy, immunohistochemistry and in-situ hybridization. The follow-up information was analyzed.

Results: The male-to-female ratio was 1.89:1. The median age of the patients was 38 years. The commonest sites of involvement included nasal cavity and adjoining tissue (85.5%). Histologically, EN-NK/TCL was composed of small to medium-sized lymphoid cells. Angiocentric and angiodestructive growth patterns, coagulative tumor necrosis and apoptotic bodies were frequently observed. Immunohistochemical study showed that CD20, the B-cell marker, was negative in all cases. The positivity rates for T-cell markers CD3epsilon, CD4, CD5 and CD8 were 100% (49/49), 7% (3/46), 8% (4/48) and 63% (29/46), respectively. Most cases were also positive for NK-cell marker CD56 (79% 42/53). All cases expressed cytotoxic granule-associated proteins TIA-1 and granzyme B. Only 17% (8/46) of the cases were positive for anti-apoptotic protein bcl-2. The proliferation index, as demonstrated by Ki-67 immunostain, varied: 30% (14/47) with a low Ki-67 expression level (< or = 29%), 28% (13/47) with a medium level (30%-59%) and 42% with a high level (> or = 60%). There was a significant positive correlation between the bcl-2 positive expression and a high Ki-67 expression level. In-situ hybridization for EBV-encoded RNA was positive in all cases. Amongst the 41 cases with clinical information available, 63.4% presented with Ann Arbor stage I to II. The performance status score was 1 in 87.8% cases. High lactate dehydrogenase level was demonstrated in some patients (31.8%). Amongst the 27 cases with follow-up data available, the median survival was 13 months. The overall 1-year, 2-year and 5-year survival rates were 52%, 31% and 20%, respectively. In general, cases with high proliferation index carried poor prognosis.

Conclusions: EN-NK/TCL is a mature T-cell and NK-cell neoplasm which can be accurately diagnosed by histologic examination, immunohistochemical study and in-situ hybridization. The prognosis is usually not favorable. Proliferation index of the tumor represents an independent prognostic factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • CD3 Complex / metabolism*
  • CD56 Antigen / metabolism
  • Child
  • Epstein-Barr Virus Infections* / virology
  • Female
  • Follow-Up Studies
  • Granzymes / metabolism
  • Herpesvirus 4, Human*
  • Humans
  • Immunophenotyping
  • Ki-67 Antigen / metabolism
  • Lymphoma, Extranodal NK-T-Cell* / metabolism
  • Lymphoma, Extranodal NK-T-Cell* / pathology
  • Lymphoma, Extranodal NK-T-Cell* / therapy
  • Lymphoma, Extranodal NK-T-Cell* / virology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Nose Neoplasms* / metabolism
  • Nose Neoplasms* / pathology
  • Nose Neoplasms* / therapy
  • Nose Neoplasms* / virology
  • Poly(A)-Binding Proteins / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • RNA, Viral / analysis
  • Retrospective Studies
  • Survival Rate
  • T-Cell Intracellular Antigen-1
  • Young Adult

Substances

  • CD3 Complex
  • CD3E protein, human
  • CD56 Antigen
  • Ki-67 Antigen
  • Poly(A)-Binding Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Viral
  • T-Cell Intracellular Antigen-1
  • TIA1 protein, human
  • Granzymes